Qinghai Spring Medicinal Resources Technology Co., Ltd.
600381.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥2,133,814 | CN¥4,530,417 | CN¥7,226,718 | CN¥4,948,922 |
| - Cash | CN¥207,219 | CN¥172,260 | CN¥168,690 | CN¥164,941 |
| + Debt | CN¥11,802 | CN¥18,659 | CN¥4,896 | CN¥1,126 |
| Enterprise Value | CN¥1,938,397 | CN¥4,376,817 | CN¥7,062,923 | CN¥4,785,107 |
| Revenue | CN¥270,264 | CN¥213,877 | CN¥160,178 | CN¥127,764 |
| % Growth | 26.4% | 33.5% | 25.4% | – |
| Gross Profit | CN¥73,630 | CN¥129,276 | CN¥73,861 | CN¥25,212 |
| % Margin | 27.2% | 60.4% | 46.1% | 19.7% |
| EBITDA | -CN¥170,896 | -CN¥231,831 | -CN¥167,010 | -CN¥178,906 |
| % Margin | -63.2% | -108.4% | -104.3% | -140% |
| Net Income | -CN¥198,766 | -CN¥267,865 | -CN¥287,550 | -CN¥248,611 |
| % Margin | -73.5% | -125.2% | -179.5% | -194.6% |
| EPS Diluted | -0.34 | -0.46 | -0.49 | -0.42 |
| % Growth | 26.1% | 6.1% | -16.7% | – |
| Operating Cash Flow | CN¥80,974 | CN¥23,917 | -CN¥31,821 | -CN¥63,934 |
| Capital Expenditures | -CN¥4,930 | -CN¥13,531 | -CN¥823 | -CN¥121,794 |
| Free Cash Flow | CN¥76,044 | CN¥10,385 | -CN¥32,644 | -CN¥185,728 |